Zixuan Xu — Nanchang University

Area of research

Cardiology and Cardiovascular Medicine · Artificial Intelligence

Research interest

Research focused on Streptozotocin and Autophagy, with related work in Relative risk, Rivaroxaban, In vivo. Notable publications include 'O-GlcNAcylation of cardiac Nav1.5 contributes to the development of arrhythmias in diabetic hearts', 'O-GlcNAc-modified SNAP29 inhibits autophagy-mediated degradation via the disturbed SNAP29-STX17-VAMP8 complex and exacerbates myocardial injury in type I diabetic rats', and 'Effectiveness and Safety of DOACs vs. VKAs in AF Patients With Cancer: Evidence From Randomized Clinical Trials and Observational Studies'.

Recent publications

Effectiveness and Safety of DOACs vs. VKAs in AF Patients With Cancer: Evidence From Randomized Clinical Trials and Observational Studies

Frontiers in Cardiovascular Medicine 2021cited by 19position: middledoi

Non-Vitamin K Antagonist Oral Anticoagulants in Secondary Stroke Prevention in Atrial Fibrillation Patients: An Updated Analysis by Adding Observational Studies

Cardiovascular Drugs and Therapy 2020cited by 10position: middledoi

O-GlcNAcylation of cardiac Nav1.5 contributes to the development of arrhythmias in diabetic hearts

International Journal of Cardiology 2018cited by 46position: middledoi

O-GlcNAc-modified SNAP29 inhibits autophagy-mediated degradation via the disturbed SNAP29-STX17-VAMP8 complex and exacerbates myocardial injury in type I diabetic rats

International Journal of Molecular Medicine 2018cited by 44position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Cardiology and Cardiovascular Medicine · Artificial Intelligence →